Your browser is no longer supported. Please, upgrade your browser.
Settings
AMPE Ampio Pharmaceuticals, Inc. daily Stock Chart
AMPE [NYSE]
Ampio Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.21 Insider Own0.10% Shs Outstand68.27M Perf Week16.27%
Market Cap40.48M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float61.65M Perf Month23.54%
Income-11.90M PEG- EPS next Q- Inst Own16.30% Short Float9.30% Perf Quarter-0.69%
Sales- P/S- EPS this Y17.30% Inst Trans-24.17% Short Ratio13.58 Perf Half Y-27.09%
Book/sh0.06 P/B9.88 EPS next Y- ROA-87.30% Target Price14.00 Perf Year-32.62%
Cash/sh0.07 P/C8.10 EPS next 5Y- ROE-188.50% 52W Range0.38 - 1.14 Perf YTD-34.13%
Dividend- P/FCF- EPS past 5Y12.80% ROI- 52W High-47.98% Beta0.00
Dividend %- Quick Ratio1.80 Sales past 5Y- Gross Margin- 52W Low56.01% ATR0.05
Employees21 Current Ratio1.80 Sales Q/Q- Oper. Margin- RSI (14)64.52 Volatility7.34% 8.86%
OptionableYes Debt/Eq1.51 EPS Q/Q55.70% Profit Margin- Rel Volume0.87 Prev Close0.55
ShortableYes LT Debt/Eq1.51 EarningsSep 26 AMC Payout- Avg Volume422.26K Price0.59
Recom- SMA2013.59% SMA5015.45% SMA200-18.21% Volume367,150 Change7.43%
Mar-17-14Reiterated Aegis Capital Buy $15 → $16
Sep-25-12Initiated Aegis Capital Buy $11
Sep-18-17 08:30AM  Ampio Completes Enrollment of Patients in 12-Week Pivotal Trial PR Newswire +6.73%
Sep-08-17 08:00AM  Ampio Pharmaceuticals, Inc. Announces Annual Shareholder Meeting PR Newswire
Sep-07-17 07:35PM  Ampio Pharmaceuticals, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference PR Newswire
04:10PM  Ampio Discloses Receipt of Notice from NYSE American and Has Until March 1, 2019, to Gain Compliance PR Newswire
Aug-08-17 08:30AM  Ampio Announces the Allowance of a Composition and Methods Patent in the USA Using Ampion in Conjunction with Stem Cells PR Newswire
Jul-06-17 01:55PM  Ampio Hosting Conference Call, Wednesday, July 12, 4:30 pm EDT PR Newswire
Jun-22-17 08:30AM  Ampio Injects First Patient in Final Pivotal Clinical Trial for Ampion BLA PR Newswire
Jun-12-17 08:30AM  Ampio Announces Appointment of Interim Chief Financial Officer PR Newswire
Jun-07-17 07:20PM  Ampio Pharmaceuticals, Inc. Announces Closing of Registered Direct Offering PR Newswire
Jun-02-17 12:16PM  Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering PR Newswire -19.71%
May-05-17 08:00AM  Ampion Human Macrophage Study Results Accepted for Presentation at the 2017 Annual AAST Meeting in Baltimore PR Newswire +16.36%
May-01-17 08:00AM  Ampio Initiates Pivotal Trial of Ampion PR Newswire +28.98%
Apr-24-17 08:00AM  The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Ampio Pharmaceuticals, Inc. -- AMPE GlobeNewswire
Mar-28-17 08:32AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
08:00AM  Ampio Pharmaceuticals Amends Warrant Agreement PR Newswire
Mar-23-17 04:28PM  Colorado biotech's accountants express 'substantial doubt' about firm's future at bizjournals.com
04:28PM  Colorado biotech's accountants express 'substantial doubt' about firm's future American City Business Journals
08:30AM  Ampio Updates Intellectual Property and Regulatory Exclusivity Strategy to Support the Commercialization of Ampion PR Newswire
Mar-22-17 04:05PM  Update - Ampio Pharmaceuticals Provides Corporate Update PR Newswire
01:04PM  AMPIO PHARMACEUTICALS, INC. Financials
Mar-20-17 08:30AM  Ampio Pharmaceuticals Provides Corporate Update PR Newswire
Mar-16-17 04:23PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
Mar-13-17 05:29PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr
Mar-01-17 08:05AM  Ampio Hosting Conference Call Tuesday, March 7, 4:30pm EST PR Newswire +5.91%
Feb-27-17 08:30AM  Ampio Receives Guidance from the FDA and Proposes a Path for Approval for Single-Injection Ampion for the Treatment of Pain Due to Severe Osteoarthritis of the Knee PR Newswire +5.45%
Jan-10-17 04:06PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-10-16 08:05AM  Ampio Updates Clinical and Regulatory Activity PR Newswire
Nov-08-16 08:09AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Oct-04-16 08:30AM  Ampio Announces Accepted Publication of the Clinical Trial Results of Its Oral Drug, Optina, Treatment of Diabetic Macular Edema PR Newswire
Sep-29-16 02:50PM  Ampio Updates Clinical and Regulatory Activity PR Newswire
Sep-08-16 12:08PM  Ampio Reports Peer-Reviewed Publication on the Potential use of Ampion in New Clinical Indications PR Newswire
Aug-30-16 08:00AM  Ampio Reports Additional Peer-Reviewed Publication on Ampion PR Newswire
Aug-29-16 05:29PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and -8.85%
11:07AM  Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering PR Newswire
Aug-03-16 08:00AM  Ampio Updates Regulatory Status of AMPION PR Newswire
06:20AM  Ampio reports 2Q loss
Aug-02-16 04:09PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Jul-13-16 07:17AM  7 Stocks Under $10 That Could Make You a Lot of Money TheStreet.com
07:17AM  7 Stocks Under $10 That Could Make You a Lot of Money
Jul-05-16 01:30PM  Ampio Hosting Conference Call Today, July 5, 4:30pm ET PR Newswire
08:00AM  Answering Two Most Important Questions Surrounding Ampio Pharmaceuticals Inc (AMPE) at Insider Monkey
Jul-03-16 09:35AM  4 Companies That Destroyed Shareholders Despite a Brexit Recovery at 24/7 Wall St.
Jun-30-16 03:57PM  Why Ampio Pharma (AMPE) Stock Is Plummeting Today -61.14%
01:42PM  Ampio Crashes After Late-Stage Trial Failure
08:38AM  Ampio Pharma stock plummets 55% after negative late-stage trial results at MarketWatch
08:38AM  Ampio Pharma stock plummets 55% after negative late-stage trial results at MarketWatch
08:05AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Ampio announces results of Ampion trials PR Newswire
May-10-16 08:30AM  Ampio Launches Clinical Trial of AMPION for the Treatment of Osteoarthritis of the Hand PR Newswire
May-06-16 09:07AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
May-03-16 08:30AM  Ampio Reports Additional Peer-Reviewed Publications on Ampion PR Newswire
Mar-29-16 04:45PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
09:19AM  Ampio Completes Enrollment in Pivotal Clinical Trial of AMPION March 29, 2016 at noodls
09:03AM  Ampio Completes Enrollment in Pivotal Clinical Trial of AMPION PR Newswire
Mar-07-16 04:45PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr
Feb-26-16 09:25AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
Feb-11-16 07:30AM  Ampio Clarifies ATM Program PR Newswire
Feb-10-16 04:46PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S
Jan-29-16 09:02AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure +5.31%
Jan-26-16 08:59AM  Ampios OptimEyes Study Results to be presented at The Association for Research in Vision and Ophthalmology (ARVO) January 26, 2016 at noodls
08:30AM  Ampio's OptimEyes Study Results to be presented at The Association for Research in Vision and Ophthalmology (ARVO) PR Newswire
Jan-25-16 08:37AM  Ampio Announces 2016 Corporate Update on Thursday, January 28, 4:30pm EST January 25, 2016 at noodls
08:30AM  Ampio Announces 2016 Corporate Update on Thursday, January 28, 4:30pm EST PR Newswire
Jan-11-16 08:30AM  Ampio's OptimEyes Study Results to be presented at World Ophthalmology Congress PR Newswire -5.93%
Dec-24-15 10:24AM  Ampio Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Dec-18-15 07:35AM  How it All Plays Out - Free Research Reports on Hill International, Marinus Pharmaceuticals, Ampio Pharmaceuticals and Cutera Accesswire
Dec-16-15 04:12PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Dec-01-15 08:30AM  The NYSE Establishes January 5, 2016 as the Ex-Distribution Date for the Ampio Distribution of Aytu BioScience Stock to Ampio Shareholders PR Newswire
Nov-23-15 07:50AM  Equity Market Movement at a Glance - Research on AxoGen, Ampio Pharmaceuticals, Ultra Clean Holdings and Willbros Group Accesswire
Nov-19-15 08:00AM  Aytu BioScience to Benefit from Share Distribution by Ampio Pharmaceuticals PR Newswire +6.15%
Nov-18-15 08:30AM  Ampio Announces Investor Call on its Aytu BioScience Common Stock Distribution on Thursday, November 19, 4:15 p.m. EST PR Newswire -5.21%
07:07AM  Q3 2015 Ampio Pharmaceuticals Inc Earnings Release - Time Not Supplied
Nov-17-15 04:51PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:30AM  Ampio Will Distribute Aytu BioSciences Stock to Ampio Shareholders of Record on December 1, 2015 PR Newswire
Nov-06-15 04:32PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Nov-05-15 04:25PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Nov-02-15 08:32AM  Ampio Intends to Distribute Aytu BioScience Stock to Ampio Shareholders PR Newswire
Oct-20-15 04:05PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
Oct-14-15 09:00AM  Ampio Pharmaceuticals, Inc. Announces Updates On the Regulatory Path for FDA Approval of Optina, an Oral Treatment for Diabetic Macular Edema (DME) PR Newswire
Oct-13-15 04:32PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
Oct-08-15 04:08PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
Oct-01-15 11:08AM  Ampio Pharmaceuticals, Inc. Earnings Q2, 2015
Sep-24-15 09:29AM  Opening Bell, September 24, 2015 +13.10%
Sep-23-15 05:32PM  Ampio (AMPE) Starts Final Phase III Study on Knee Pain Drug -7.12%
Sep-22-15 12:46PM  Ampio Pharmaceuitcals (AMPE) Stock Spikes After Receiving FDA Special Protocol Assessment at TheStreet +5.97%
11:25AM  Is the Surge in Ampio Sustainable?
08:00AM  AMPIO Receives Special Protocol Assessment (SPA) from the FDA and Commences Second Phase III pivotal trial of Ampion PR Newswire
Aug-10-15 08:13PM  10-Q for Ampio Pharmaceuticals, Inc. at Company Spotlight
Aug-07-15 08:04AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Aug-06-15 08:02AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr
Jul-17-15 11:30AM  Ampio Hosts Investor Call to Discuss Updates on Ampion and Optina PR Newswire
Jul-09-15 12:10PM  Ampio Announces Investor Call on Thursday, July 16, 4:30 p.m. EDT PR Newswire
Jul-06-15 10:41AM  24-Hour Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of July 7 Deadline in the Class Action Filed on Behalf of Ampio Pharmaceuticals, Inc. Investors Business Wire
Jul-03-15 10:46PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Advises Shareholders to Contact the Firm Prior to the Lead Plaintiff Deadline Business Wire
Jul-01-15 03:30PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ampio Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2015 -- AMPE GlobeNewswire
11:57AM  INVESTOR ALERT: Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. Announced by Glancy Prongay & Murray LLP Business Wire
Jun-30-15 08:45PM  IMPORTANT SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors That a Federal Securities Class Action Has Been Filed Against Ampio Pharmaceuticals, Inc. - AMPE GlobeNewswire
Jun-26-15 05:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AMPE PR Newswire
Jun-23-15 10:23AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ampio Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 10, 2015 -- AMPE Marketwired
Jun-22-15 08:30AM  Ampio Pharmaceuticals Announces Additional Statistically Significant Study Results for Optina in the Treatment of Diabetic Macular Edema (DME) PR Newswire
Ampio Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, which has completed Phase II clinical trials for diabetic macular edema. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.